4//SEC Filing
TRIANGLE PHARMACEUTICALS INC 4
Accession 0001185955-03-000002
CIK 0000000000operating
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 4:59 PM ET
Size
19.3 KB
Accession
0001185955-03-000002
Insider Transaction Report
Form 4
Fresne, Donald C.
10% Owner
Transactions
- Exercise/Conversion
Common Stock
2003-01-10$2.55/sh+9,999$25,497→ 2.55 total - Exercise/Conversion
Stock Options (rights to buy)
2003-01-10−9,999Exercise: $2.55→ Common Stock (9,999 underlying)
Documents
Issuer
Triangle Pharmaceuticals, Inc.
CIK 0000000000
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001022622
Filing Metadata
- Form type
- 4
- Filed
- Jan 12, 7:00 PM ET
- Accepted
- Jan 13, 4:59 PM ET
- Size
- 19.3 KB